Jenburkt Pharmaceuticals Ltd. - Research Center
524731 JENBURPH Group (X) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
38.84 |
35.66 |
38.29 |
29.18 |
35.20 |
Operating profit |
9.85 |
7.19 |
9.10 |
6.97 |
7.50 |
Interest |
0.06 |
0.07 |
0.07 |
0.07 |
0.08 |
Gross profit |
10.98 |
8.47 |
10.13 |
7.93 |
8.67 |
EPS (Rs) |
17.86 |
12.25 |
16.59 |
12.17 |
14.40 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
1.19 |
1.35 |
1.10 |
1.04 |
1.26 |
Stock adjustment |
0.63 |
0.28 |
1.40 |
-2.71 |
2.90 |
Raw material |
2.52 |
2.15 |
1.68 |
2.05 |
2.63 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
10.38 |
11.56 |
10.89 |
9.66 |
9.12 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
15.46 |
14.48 |
15.21 |
13.21 |
13.05 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.62 |
0.63 |
0.59 |
0.50 |
0.59 |
Taxation |
2.48 |
2.44 |
2.22 |
2.06 |
1.72 |
Net profit / loss |
7.88 |
5.40 |
7.32 |
5.37 |
6.35 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
4.41 |
4.41 |
4.41 |
4.41 |
4.41 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
25.37 |
20.18 |
23.78 |
23.88 |
21.30 |
GPM (%) |
27.44 |
22.89 |
25.72 |
26.25 |
23.78 |
NPM (%) |
19.69 |
14.60 |
18.59 |
17.77 |
17.43 |